Abstract
Leucine amino peptidase (LAP) activity was studied in serum and urine samples of 25 healthy ambulant subjects, 20 patients with localised and 41 patients with malignant disseminated disease. Serum levels of the enzyme were elevated but not significantly in both localised and disseminated disease whereas the urinary activity of the enzyme was markedly elevated in disseminated disease (p<0.001) as compared to localised disease. This quantitative method used for determination is reliable, accurate, simple, rapid and cost effective and therefore has better application as an indicator of disseminated disease in a clincal setting.
Similar content being viewed by others
References
Arst, H.E., Manning, R.T. and Delp, M. (1959) Serum leucine amino peptidase activity: findings in carcinoma of the pancreas, pregnancy and other disorders. Am. J. Med. Sc. 238, 598–609.
Bressler, R., Forsyth, B.R. and Klatskin, G. (1960) Serum leucine amino peptidase activity in hepatobiliary and pancreatic disease. J. Lab. & Clin. Med. 56, 417–430.
Derrick, J.B., Heagy, F.C., Urtasun, R. and Swartz, D.P. (1963) A comparison of the leucine amino peptidase with the hepatoscan in the investigation of suspected liver metastasis. Clin. Chem. 9, 448–449.
Sathe, S.B. and Taskar, S.P. (1982) Leucine amino peptidase levels in hepatic and certain gastrointestinal tract cancers. JAPI. 30, 83.
Ghadge, M.S., Sirsat, A.V., Bhansali, M.S., Desouza, L.J. and Jagannath, P. (2001) Leucine amino peptidase a better indicator of carcinoma of liver, biliary tract and pancreas. Ind. J. Clin. Biochem. 16, 60–64.
Szasz, G. (1964) Serum leucine amino peptidase activity in acute lesions of the liver parenchyma. Lancet, i, 441–442.
Khanolkar, M.M., Sirsat, A.V., Deshmane, V.H. and Kamat, M.R. (1992) Serum leucine amino peptidase levels as markers in testicular tumors. Ind. J. Med. Res. 96, 372–375.
Szasz, G. (1967) A kinetic photometric method for serum leucine amino peptidase. Am. J. Clin. Path. 47, 607–613.
Larsen, K. (1972). Creatinine assay by a reaction kinetic principle. Clin. Chim. Acta 41, 209.
Phillips, R.W. and Manildi, E.R. (1970) Elevation of leucine amino peptidase in disseminated malignant disease. Cancer, 26, 1006–1012.
Rutenburg, A.M., Goldberg, J.A. and Pineda, E.P. (1958) Leucine aminopeptidase activity Observations in patients with cancer of pancreas and other diseases. New Engl. J. Med. 259, 469–472.
Hoffman, E., Nachlas, M.M., Gaby, S.D., Abrams, S.J. and Seligman, A.M. (1960) Limitations in the diagnostic value of serum leucine aminopeptidase. New Engl. J. Med. 263, 541–544.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ghadge, M.S., Raste Leucine amino peptidase a better indicator of disseminated malignant disease. Indian J Clin Biochem 19, 149–151 (2004). https://doi.org/10.1007/BF02894275
Issue Date:
DOI: https://doi.org/10.1007/BF02894275